Daclit^®

Therapeutic Segment:
Anti-viral

Generic Name:
Daclatasvir

Description:
DACLIT (daclatasvir) is an inhibitor of HCV nonstructural protein 5A (NS5A).

Indication:
DACLIT is indicated for use with sofosbuvir, with or without ribavirin, for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection.

Formulation:

• Tablets

Strength:

• 60mg

Pack Size:

• 28’s